Document is current
Any future updates will be listed below
-
Authors
Provido, Sherlyn Mae P.
Abris, Grace P.
Lee, Heejin
Okekunle, Akinkunmi Paul
Gironella, Glen Melvin
Capanzana, Mario V.
Chung, Grace H.
Hong, Sangmo
Yu, Sung Hoon
Lee, Chang Beom
Lee, Jung Eun
-
Funding
Funding for this research was provided by:
Hanmi Pharmaceutical Co., Ltd. (No. 201300000001270)
Chong Kun Dang Pharm, Seoul, Korea (No. 201600000000225)
Yuhan Corporation
National Research Foundation of Korea (2020H1D3A1A04081265)
- License Information
-
More Information
Article History
Received: 13 June 2022
Accepted: 8 February 2023
First Online: 30 March 2023
Declarations
:
: The study was approved by the Institutional Review Board of Sookmyung Women’s University (No. SMWU-1311BR-01), Seoul National University (IRB No.1904/002-011/IRB No.1710/002-003) and Hanyang University (HYUIRB-202008-014-2). The study was conducted in accordance with the ethical principle of Helsinki Declaration. An informed written consent was obtained from all study participants of four studies (FiLWHEL, NNS, NHANES and KNHANES) before the study was conducted.
: Not applicable.
: The authors declare that they have no competing interests.
